Northwest Biotherapeutics | NWBO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agenus USD 3.46M 6.08M 2025-09
AstraZeneca USD 8.14B 1.08B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celldex Therapeutics USD 28.87M 7.17M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
Merck USD 18.17B 10.16B 2025-09
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Pfizer USD 1.34B 295M 2025-09
Plus Therapeutics USD 8.55M 2.45M 2023-12
Roche Holding CHF 7.55B 579M 2025-06